UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
NAMS holding history
NewAmsterdam Pharma Co N.V. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NAMS overviewAll 13F holders of NAMSFull Q2 2026 holdings
- Shares (Q2 2026)
- 344,065
- Value
- $11.7M
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 344,065 | $11.7M | <0.1% | −450,911−56.7% | Reduced | Holders |
| Q1 2026 | 794,976 | $25.4M | <0.1% | −104,466−11.6% | Reduced | Holders |
| Q4 2025 | 899,442 | $31.6M | <0.1% | +130,922+17.0% | Added | Holders |
| Q3 2025 | 768,520 | $21.9M | <0.1% | +140,801+22.4% | Added | Holders |
| Q2 2025 | 627,719 | $11.4M | <0.1% | +229,576+57.7% | Added | Holders |
| Q1 2025 | 398,143 | $8.15M | <0.1% | +317,933+396.4% | Added | Holders |
| Q4 2024 | 80,210 | $2.06M | <0.1% | −50,030−38.4% | Reduced | Holders |
| Q3 2024 | 130,240 | $2.16M | <0.1% | +124,171+2,046.0% | Added | Holders |
| Q2 2024 | 6,069 | $116.6K | <0.1% | −42,210−87.4% | Reduced | Holders |
| Q1 2024 | 48,279 | $1.14M | <0.1% | +47,479+5,934.9% | Added | Holders |
| Q4 2023 | 800 | $8.94K | <0.1% | +800 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −183−100.0% | Sold out | Holders |
| Q2 2023 | 183 | $2.18K | <0.1% | +183 | New | Holders |